Efficacy of Zoledronic Acid to Prevent Bone Loss Following Denosumab Discontinuation

Clinical trial NCT05405894 · UNKNOWN

Trial details

NCT number: NCT05405894
Sponsor: University of Calgary
Status: UNKNOWN
Study type: OBSERVATIONAL

Osteoporosis Osteoporosis, Postmenopausal Osteopenia Bone Loss

Start date: 2022-09-01
Primary completion: 2024-07-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.